Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
Vanda Pharmaceuticals (VNDA) has announced its participation in two major investor conferences in November 2024. The company will deliver a corporate presentation at the Stifel 2024 Healthcare Conference on November 19 at 9:45 a.m. ET, followed by a fireside chat at the Jefferies 2024 London Healthcare Conference on November 21 at 11:30 a.m. GMT. Both events will be accessible live through Vanda's corporate website, with archived recordings available for approximately 30 days afterward.
Vanda Pharmaceuticals (VNDA) ha annunciato la sua partecipazione a due importanti conferenze per investitori a novembre 2024. L'azienda presenterà una relazione aziendale alla Stifel 2024 Healthcare Conference il 19 novembre alle 9:45 a.m. ET, seguita da una chiacchierata informale alla Jefferies 2024 London Healthcare Conference il 21 novembre alle 11:30 a.m. GMT. Entrambi gli eventi saranno accessibili in diretta tramite il sito web aziendale di Vanda, con registrazioni archiviate disponibili per circa 30 giorni dopo.
Vanda Pharmaceuticals (VNDA) ha anunciado su participación en dos importantes conferencias para inversores en noviembre de 2024. La empresa realizará una presentación corporativa en la Stifel 2024 Healthcare Conference el 19 de noviembre a las 9:45 a.m. ET, seguida de una conversación informal en la Jefferies 2024 London Healthcare Conference el 21 de noviembre a las 11:30 a.m. GMT. Ambos eventos estarán disponibles en vivo a través del sitio web corporativo de Vanda, con grabaciones archivadas disponibles durante aproximadamente 30 días después.
반다 제약(VNDA)는 2024년 11월에 열리는 두 개의 주요 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 11월 19일 오전 9시 45분(ET)에 스티펠 2024 헬스케어 컨퍼런스에서 기업 발표를 진행하며, 11월 21일 오전 11시 30분(GMT)에는 제퍼리스 2024 런던 헬스케어 컨퍼런스에서 대담을 진행합니다. 두 행사 모두 반다의 기업 웹사이트를 통해 실시간으로 시청할 수 있으며, 약 30일 후에는 녹화된 자료도 이용 가능합니다.
Vanda Pharmaceuticals (VNDA) a annoncé sa participation à deux grandes conférences pour investisseurs en novembre 2024. L'entreprise présentera une communication d'entreprise lors de la Stifel 2024 Healthcare Conference le 19 novembre à 9h45 ET, suivie d'une discussion informelle lors de la Jefferies 2024 London Healthcare Conference le 21 novembre à 11h30 GMT. Les deux événements seront accessibles en direct via le site web de Vanda, avec des enregistrements archivés disponibles pendant environ 30 jours par la suite.
Vanda Pharmaceuticals (VNDA) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 19. November um 9:45 Uhr ET eine Unternehmenspräsentation auf der Stifel 2024 Healthcare Conference halten, gefolgt von einem informellen Gespräch auf der Jefferies 2024 London Healthcare Conference am 21. November um 11:30 Uhr GMT. Beide Veranstaltungen werden live über die Unternehmenswebsite von Vanda zugänglich sein, und aufgezeichnete Aufnahmen werden etwa 30 Tage lang verfügbar sein.
- None.
- None.
The Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024. A corporate presentation is scheduled for 9:45 a.m. Eastern Time.
The Jefferies 2024 London Healthcare Conference on Thursday, November 21, 2024. A fireside chat is scheduled for 11:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time).
The corporate presentation and fireside chat given at the Stifel and Jefferies conferences, respectively, may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2024-investor-conferences-302303384.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) presenting at the Stifel Healthcare Conference 2024?
What time is Vanda Pharmaceuticals' (VNDA) fireside chat at the Jefferies London Healthcare Conference 2024?
How long will Vanda Pharmaceuticals' (VNDA) November 2024 conference presentations be available online?
